Dermagraft

DEVICE3 trials

Sponsors

Organogenesis, VA Office of Research and Development, Shire Regenerative Medicine, Inc.

Conditions

Diabetic Foot UlcerVenous Leg Ulcer

Phase 3

Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers

CompletedNCT01181453

OrganogenesisDiabetic Foot Ulcer

Start: 1998-12-31End: 2000-03-31Updated: 2018-05-21

VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic

CompletedNCT01450943

VA Office of Research and DevelopmentDiabetic Foot Ulcer

Start: 2011-10-01End: 2018-04-04Updated: 2019-09-17

Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers

CompletedNCT01891760

Shire Regenerative Medicine, Inc.Venous Leg Ulcer

Start: 2010-05-31End: 2012-06-30Updated: 2013-08-21